Standout Papers

CircXRN2 suppresses tumor... 2023 2026 2024 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer
    2023 128 citations Bo Xie, Xianwu Chen et al. Molecular Cancer profile →

Immediate Impact

53 hit
Sub-graph 1 of 23

Citing Papers

The emerging role of protein l-lactylation in metabolic regulation and cell signalling
2025 Hit
Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives
2025 Hit
1 intermediate paper

Works of Zhenghui Hu being referenced

CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer
2023 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zhenghui Hu 265 160 87 80 61 35 612
Jiquan Wang 181 0.7× 65 0.4× 21 0.2× 37 0.5× 36 0.6× 33 585
Joana Santos 242 0.9× 140 0.9× 17 0.2× 44 0.6× 46 0.8× 32 677
Sheng-Jun Wang 215 0.8× 118 0.7× 133 1.5× 24 0.3× 20 0.3× 57 671
Jinghua Wang 226 0.9× 88 0.6× 11 0.1× 99 1.2× 56 0.9× 29 558
Wei Li 167 0.6× 89 0.6× 80 0.9× 28 0.3× 9 0.1× 54 612
Yulong Liu 270 1.0× 70 0.4× 19 0.2× 58 0.7× 37 0.6× 68 566
Zuojun Wang 167 0.6× 124 0.8× 49 0.6× 89 1.1× 25 0.4× 42 527
Yiran Chen 211 0.8× 63 0.4× 37 0.4× 74 0.9× 78 1.3× 48 640
Yuehua Xu 143 0.5× 42 0.3× 130 1.5× 99 1.2× 66 1.1× 29 684
Toshiyuki Kano 397 1.5× 26 0.2× 42 0.5× 27 0.3× 15 0.2× 26 665

All Works

Loading papers...

Rankless by CCL
2026